Enzyme catalyzed therapeutic agents

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C536S026800

Reexamination Certificate

active

07601703

ABSTRACT:
This invention provides a method for identifying potential therapeutic agents by contacting a target cell with a candidate therapeutic agent which is a selective substrate for an endogenous, intracellular enzyme in the cell which is enhanced in its expression as a result of selection by biologic or chemotherapy. This invention also provides methods and examples of molecules for selectively killing a pathological cell by contacting the cell with a prodrug that is a selective substrate for an endogenous, intracellular enzyme. The prodrug is subsequently converted to a cellular toxin. Further provided by this invention is a method for treating a pathology characterized by pathological, hyperproliferative cells in a subject by administering to the subject a prodrug that is a selective substrate for an endogenous, overexpressed, intracellular enzyme, and converted by the enzyme to a cellular toxin in the hyperproliferative cell.

REFERENCES:
patent: 3852266 (1974-12-01), Kiyanagi et al.
patent: 4247544 (1981-01-01), Bergstrom et al.
patent: 4267171 (1981-05-01), Bergstrom et al.
patent: 4542210 (1985-09-01), Sakata et al.
patent: 4668777 (1987-05-01), Caruthers et al.
patent: 4816570 (1989-03-01), Farquhar
patent: 4948882 (1990-08-01), Ruth
patent: 4963263 (1990-10-01), Kauver
patent: 4963533 (1990-10-01), De Clercq et al.
patent: 4975278 (1990-12-01), Senter et al.
patent: 5070082 (1991-12-01), Murdock et al.
patent: 5077282 (1991-12-01), Murdock et al.
patent: 5077283 (1991-12-01), Murdock et al.
patent: 5085983 (1992-02-01), Scanlon
patent: 5116822 (1992-05-01), De Clercq et al.
patent: 5116827 (1992-05-01), Murdock et al.
patent: 5133866 (1992-07-01), Kauver
patent: 5137724 (1992-08-01), Balzarini et al.
patent: 5212161 (1993-05-01), Moriniere et al.
patent: 5212291 (1993-05-01), Murdock et al.
patent: 5217869 (1993-06-01), Kauver
patent: 5233031 (1993-08-01), Borch et al.
patent: 5264618 (1993-11-01), Felgner et al.
patent: 5274162 (1993-12-01), Glazier
patent: 5300425 (1994-04-01), Kauver
patent: 5338659 (1994-08-01), Kauver et al.
patent: 5430148 (1995-07-01), Webber et al.
patent: 5433955 (1995-07-01), Bredehorst et al.
patent: 5457187 (1995-10-01), Gmeiner et al.
patent: 5459127 (1995-10-01), Felgner et al.
patent: 5502037 (1996-03-01), Kondratyev
patent: 5516631 (1996-05-01), Frisch
patent: 5521161 (1996-05-01), Malley et al.
patent: 5527900 (1996-06-01), Balzarini et al.
patent: 5556942 (1996-09-01), Kauvar et al.
patent: 5596018 (1997-01-01), Baba et al.
patent: 5616564 (1997-04-01), Rapaport et al.
patent: 5627165 (1997-05-01), Glazier
patent: 5645988 (1997-07-01), Vande Woude et al.
patent: 5663321 (1997-09-01), Gmeiner et al.
patent: 5705336 (1998-01-01), Reed et al.
patent: 5733896 (1998-03-01), Holý et al.
patent: 5798340 (1998-08-01), Bischofberger et al.
patent: 5968910 (1999-10-01), Balzarini
patent: 5981507 (1999-11-01), Josephson et al.
patent: 5998151 (1999-12-01), Johnston et al.
patent: 6057305 (2000-05-01), Holý et al.
patent: 6245750 (2001-06-01), Shepard
patent: 6339151 (2002-01-01), Shepard et al.
patent: 6495553 (2002-12-01), Shepard
patent: 6589941 (2003-07-01), Fahrig et al.
patent: 6599499 (2003-07-01), Rosen et al.
patent: 6677314 (2004-01-01), Klecker et al.
patent: 6677315 (2004-01-01), Klecker et al.
patent: 6682715 (2004-01-01), Klecker et al.
patent: 6683045 (2004-01-01), Klecker et al.
patent: 6683061 (2004-01-01), Shepard et al.
patent: 6703374 (2004-03-01), Klecker et al.
patent: 7138388 (2006-11-01), Shepard
patent: 2001/0016329 (2001-08-01), Shepard
patent: 2001/0034440 (2001-10-01), Shepard et al.
patent: 2002/0022001 (2002-02-01), Klecker et al.
patent: 2002/0034473 (2002-03-01), Klecker et al.
patent: 2002/0119094 (2002-08-01), Klecker et al.
patent: 2002/0147175 (2002-10-01), Shepard et al.
patent: 2002/0151519 (2002-10-01), Shepard et al.
patent: 2002/0165199 (2002-11-01), Klecker et al.
patent: 2003/0049201 (2003-03-01), Klecker et al.
patent: 2003/0095921 (2003-05-01), Klecker et al.
patent: 32 29 169 (1984-02-01), None
patent: 0 095 294 (1983-11-01), None
patent: 0 283 065 (1988-09-01), None
patent: 0 311 107 (1989-04-01), None
patent: 0 311 108 (1989-04-01), None
patent: 0 316 592 (1989-05-01), None
patent: 982776 (1965-02-01), None
patent: 88451 (1986-01-01), None
patent: WO 89/05817 (1989-06-01), None
patent: WO 90/03978 (1990-04-01), None
patent: WO 91/17424 (1991-11-01), None
patent: WO 92/19767 (1992-11-01), None
patent: WO 92/20344 (1992-11-01), None
patent: WO 94/03467 (1994-02-01), None
patent: WO 94/22483 (1994-10-01), None
patent: WO 95/01806 (1995-01-01), None
patent: 9508556 (1995-03-01), None
patent: WO 95/08556 (1995-03-01), None
patent: WO 95/09865 (1995-04-01), None
patent: WO 95/12678 (1995-05-01), None
patent: WO 96/03151 (1996-02-01), None
patent: WO 96/07413 (1996-03-01), None
patent: WO 96/07431 (1996-03-01), None
patent: 9610030 (1996-04-01), None
patent: WO 96/10300 (1996-04-01), None
patent: WO 96/29336 (1996-06-01), None
patent: WO 96/23506 (1996-08-01), None
patent: WO 96/33168 (1996-10-01), None
patent: 9640708 (1996-12-01), None
patent: WO 96/40088 (1996-12-01), None
patent: WO 96/40708 (1996-12-01), None
patent: WO 96/40739 (1996-12-01), None
patent: WO 97/25342 (1997-07-01), None
patent: WO 97/28179 (1997-08-01), None
patent: WO 97/49717 (1997-12-01), None
patent: WO 98/49177 (1998-11-01), None
patent: WO 99/06072 (1999-02-01), None
patent: WO 99/08110 (1999-02-01), None
patent: 9920741 (1999-04-01), None
patent: WO 99/20741 (1999-04-01), None
patent: WO 99/37753 (1999-07-01), None
patent: WO 00/18755 (2000-04-01), None
patent: WO 00/33888 (2000-06-01), None
patent: WO 01/07454 (2001-02-01), None
patent: WO 01/07888 (2001-02-01), None
patent: WO 01/83501 (2001-11-01), None
patent: WO 01/85749 (2001-11-01), None
Berkow et al. (eds.),The Merck Manual of Diagnosis and Therapy, 16th Ed., Merck & Co., Rahway, NJ, May 1992, only p. 1278 supplied.
Firestone et al., “A Comparison of the Effects of Antitumor Agents Upon Normal Human Epidermal Keratinocytes and Human Squamous Cell Carcinoma,”Journal of Investigative Dermatology, 94(5), 657-661 (May 1990).
Dagle et al., “Targeted Degradation of mRNA inXenopusoocytes and Embryos Directed by Modified Oligonucleotides: Studies of An2 and Cyclin in Embryogenesis,”Nucleic Acids Research, 18(16), 4751-4757 (Aug. 25, 1990).
Hakimelahi et al., “Design, Synthesis, and Structure-Activity Relationship of Novel Dinucleotide Analogs as Agents Against Herpes and Human Immunodeficiency Viruses,”Journal of Medicinal Chemistry, 38(23), 4648-4659 (Nov. 10, 1995).
Naesens et al., “Anti-HIV Activity and Metabolism of Phosphoramidate Derivatives of D4T-MP with Variations in the Amino Acid Moiety,” Poster Session 1, The Tenth International Conference on Antiviral Research, Hotel Nikko, Atlanta, GA, Apr. 6-11, 1997; published inAntiviral Research, 34(2), p. A54 (Abstract 40), (Apr. 1997).
Evrard et al., “An in vitro Nucleoside Analog Screening Method for Cancer Gene Therapy,”Cell Biology and Toxicology, 12, 345-350 (1996).
Morrison & Boyd (eds.),Organic Chemistry, Allyn & Bacon, Inc., Boston, MA, 1973, onlyh pp. 1170-1180 supplied.
L. B. Townsend (ed.),Chemistry of Nucleosides and Nucleotides, vol. 3, Plenum Press, New York, NY, 1974, only Table of Contents, Bibliograhy pp. 529-535, and Index pp. 537-552 supplied.
L. B. Townsend (ed.),Chemistry of Nucleosides and Nucleotides, vol. 3, Plenum Press, New York, NY, 1974, only Table of Contents, Bibliography pp. 529-535, and Index pp. 537-552 supplied.
The American Heritage College Dictionary, Third Edition, Houghton Mifflin Co., New York, NY, 1997, only p. 668 supplied.
L. B. Townsend (ed.),Chemistry of Nucleosides and Nucleotides, vol. 3, Plenum Press, New York, NY, 1974, only Table of Contents, Bibliography pp. 529-535, and Index pp. 537-552 supplied.
Pugh et al. (eds.),Stedman's Medical Dictionary, 27th Edition, Lippincott Willliams & Wilkins, Philadelphia, PA, 2000, only pp. 1188-1189 supplied.
Beers et al. (eds.),Merck Manual of Diagn

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Enzyme catalyzed therapeutic agents does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Enzyme catalyzed therapeutic agents, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Enzyme catalyzed therapeutic agents will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-4120937

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.